Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
BT-20
TNBC
Basal A
IKK16
IKK
NFKB
5904.1
uM
3.2630
4.78830
-0.9364 -0.9398 2.7575 0.4257
0.9913
1.3369
BT-20
TNBC
Basal A
IKK16
IKK
NFKB
10385.093
uM
3.54330
4.41410
-0.9989 -1.0000 4.9997 0.3819
0.9982
0.6082
BT-20
TNBC
Basal A
Imatinib
ABL/KIT/PDGFR
nRTK
5904.092
uM
7.68060
18.45430
-0.9954 -1.0000 1.2533 0.6283
0.9466
0.8933
BT-20
TNBC
Basal A
Imatinib
ABL/KIT/PDGFR
nRTK
5903.09
uM
14.23390
26.11670
-0.9964 -1.0000 1.8101 0.5188
0.9862
0.9291
BT-20
TNBC
Basal A
Imatinib
ABL/KIT/PDGFR
nRTK
5902.091
uM
25.1560
35.74990
-0.9699 -0.9762 3.0805 0.4234
0.9972
1.1648
BT-20
TNBC
Basal A
Ispinesib
KSP
Kinesin
5902.067
uM
0.02739
0.47554
-0.9786 -1.0000 0.3849 0.6756
0.8442
1.1750
BT-20
TNBC
Basal A
Ispinesib
KSP
Kinesin
5903.067
uM
0.01561
0.02594
-0.9863 -0.4826 1.3299 0.8003
0.9066
1.2584
BT-20
TNBC
Basal A
Ispinesib
KSP
Kinesin
5904.067
uM
0.01503
0.02069
-0.9957 -0.5464 2.3099 0.8668
0.9421
1.0398
BT-20
TNBC
Basal A
Ixabepilone
TUBB
TUBB
10385.095
uM
0.00319
0.00514
-0.9980 -0.5798 1.6199 1.0590
0.9374
0.7986
BT-20
TNBC
Basal A
Ixabepilone
TUBB
TUBB
5902.095
uM
0.00775
0.01266
-0.9806 -0.5587 1.5290 0.9318
0.9485
1.0245
BT-20
TNBC
Basal A
Ixabepilone
TUBB
TUBB
5904.095
uM
0.00177
0.00213
-0.9973 -0.7751 4.9993 1.3519
0.9867
0.6537
BT-20
TNBC
Basal A
JNK-IN-5A
JNK
JNK
10581.144
uM
1.46850
1.58040
-0.3485 -0.2218 5.0000 0.4645
0.9194
1.2048
BT-20
TNBC
Basal A
JNK-IN-5A
JNK
JNK
11854.144
uM
0.55999
0.64447
-0.2555 -0.2061 2.4565 0.4840
0.9967
1.3102
BT-20
TNBC
Basal A
L-779450
BRAF
MAPK
10581.137
uM
inf
10.00460
0.5092 0.5077 4.7765 0.0869
0.7337
1.1975
BT-20
TNBC
Basal A
L-779450
BRAF
MAPK
11854.161
uM
34.51650
42.99810
-0.3604 -1.0000 5.0000 0.0676
0.9896
1.2085
BT-20
TNBC
Basal A
Lapatinib
EGFR/HER2
ErbB
5902.098
uM
inf
inf
0.9860 0.9860 0.0000 -0.0045
-0.0403
1.1137
BT-20
TNBC
Basal A
Lapatinib
EGFR/HER2
ErbB
5904.098
uM
inf
inf
0.8819 0.8819 0.0000 0.0368
0.3491
1.3264
BT-20
TNBC
Basal A
LBH589
HDAC
HDAC
11854.154
uM
0.35741
0.53161
-0.6250 -0.5778 1.9345 0.5130
0.9932
1.3146
BT-20
TNBC
Basal A
Lestaurtinib
FLT3/JAK2/TrkA
RTK
11854.154
uM
3.30110
6.51830
-0.9271 -1.0000 1.6148 0.3215
0.9831
1.3146
BT-20
TNBC
Basal A
Lestaurtinib
FLT3/JAK2/TrkA
RTK
10581.142
uM
2.83260
4.6630
-0.9968 -1.0000 2.2041 0.5323
0.9899
0.7885
BT-20
TNBC
Basal A
Mebendazole
13579.174
uM
0.58296
2.17040
-0.7093 -0.7012 0.6667 0.4704
0.8992
0.8018
BT-20
TNBC
Basal A
Methotrexate
DHFR
Metabolism
5904.085
uM
inf
inf
1.0500 1.0500 0.0000 -0.0334
-1.4110
1.2247
BT-20
TNBC
Basal A
Methotrexate
DHFR
Metabolism
5902.084
uM
inf
inf
0.9945 0.9945 0.0000 -0.0077
-0.0317
1.3532
BT-20
TNBC
Basal A
Methotrexate
DHFR
Metabolism
5903.084
uM
inf
inf
1.0102 1.0102 0.0000 0.0105
0.0000
1.2088
BT-20
TNBC
Basal A
Methylglyoxal
13599.184
uM
500.64850
581.97960
-0.9120 -0.5613 5.0000 0.6654
0.8086
0.8566